SS-31 acts like a “mechanic” for your cells’ power plants (mitochondria). It specifically targets cardiolipin, a lipid in the inner mitochondrial membrane that is essential for energy production but easily damaged by aging and stress.

Reported Benefits & 2026 Clinical Data

As of March 2026, SS-31 has been one of the most researched longevity peptides, with several key areas of focus:

• Mitochondrial “Repair”: SS-31 stabilizes the mitochondrial structure, reducing “electron leakage” (which causes oxidative stress) and increasing ATP production (cellular energy).
• Heart Health: Data from trials like the TACTIC and HFpEF studies show that SS-31 can improve cardiac strain and diastolic function. It is being heavily investigated for “Heart Failure with Preserved Ejection Fraction,” a condition with few other treatments.
• Kidney Protection: Clinical reports highlight its ability to reduce inflammation and oxidative damage in the kidneys, particularly in cases of Diabetic Nephropathy and acute kidney injury.
• Muscle Performance: In aging models, SS-31 has been shown to improve muscle force and fatigue resistance by restoring the sensitivity of mitochondria to ADP, effectively “tuning up” old muscle fibers to act younger.
• Neuroprotection: Preclinical data (2025-2026) suggests potential benefits for cognitive decline and recovery from traumatic brain injury (TBI) by preventing neuronal cell death caused by mitochondrial “bursting.”

SS-31 vs. Standard Antioxidants